CP

CSO Placeholder

Chief Scientific Officer

Whitehawk Therapeutics

Therapeutic Areas

Whitehawk Therapeutics Pipeline

DrugIndicationPhase
WHK-001Advanced Solid Tumors (including Recurrent Glioblastoma and NSCLC)Phase 1/2